NET LOSS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of Earnings per Shares, basic and diluted

The table below sets forth a reconciliation of the basic and diluted earnings per share (“EPS”) calculations for the years ended December 31, 2024 and 2023:


	For the Year Ended December 31,
($ in thousands, except share and per share amounts)	2024		2023
Numerator:
Net loss	$	(146,076)	$	(167,042)

Denominator:
Weighted average shares outstanding - basic	19,246,799		16,761,646
Effect of dilutive equity awards (1)	—		—
Weighted average shares outstanding - diluted	19,246,799		16,761,646

Net loss per share:
Basic	$	(7.59)	$	(9.97)
Diluted	$	(7.59)	$	(9.97)

(1) Due to the Company’s net loss, all unvested equity awards and the private placement warrants are anti-dilutive. The dilutive convertible instruments of the Backstop Notes are out of the money.

Schedule of Diluted Shares Outstanding

Set forth in the table below is the number of securities not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:


	For the Year Ended December 31,
	2024	2023
Common stock issuable due to grants of RSUs with service only (i.e., time-vesting) conditions	1,022,014	1,238,750
Common stock issuable on conversion of the Backstop Notes (1)	1,920,007	1,920,007
Common stock issuable on exercise of private placement warrants	54,556	54,556

(1) Common stock issuable under the Backstop Notes is presented at the maximum number of shares of common stock potentially issuable upon the exercise of the Backstop Notes, although the actual potentially issuable shares remain limited at 9.9% of the common stock outstanding at the time of any exercise. Common stock issuable and exercise price has been adjusted for the reverse stock split as described in Note 9 — Long-Term Debt and Other Borrowings, Net.